Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children's Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Redefining Osteosarcoma Metastases as Chronic Non-healing Lung Wounds: Implications for Developing Novel Therapies |
Research Institute at Nationwide Children's Hospital / James Reinecke, MD/PhD |
Young Investigator Grants |
2021 |
Ohio |
Targeting CCAAT/enhancer binding proteins CEBPB and CEBPD in neuroblastoma |
Columbia University / Darrell Yamashiro, MD/PhD |
Innovation Grants |
2021 |
New York |
Targeting tumor associated macrophages in metastatic Ewing sarcoma (ES) |
New York Medical College / Mitchell Cairo, MD |
Innovation Grants |
2021 |
New York |
A leukemia organoid platform for dissection and targeting of tumor-niche interactions |
Columbia Institute for Cancer Genetics / Adolfo Ferrando, MD/PhD |
Innovation Grants |
2021 |
New York |
Phosphopeptides as shared targets for donor derived T cell therapy of AML |
Memorial Sloan-Kettering Cancer Center / Richard O'Reilly, MD |
Innovation Grants |
2021 |
New York |
IND-Enabling Studies for WNTinib, a Novel Selective Therapeutic for CTNNB1 Mutant Hepatoblastomas |
Icahn School of Medicine at Mount Sinai / Ernesto Guccione, PhD & Josep Llovet, MD & Arvin Dar, PhD |
Reach Grants |
2021 |
New York |
Optimization of Drug Efflux and Brain Clearance to Improve CED of Targeted Therapy to H3K27M DMG |
Mayo Clinic / David Daniels, MD/PhD |
Reach Grants |
2021 |
Minnesota |
Unraveling metabolic dependencies in childhood supratentorial ependymomas. |
Regents of the University of Michigan / Sriram Venneti, MD/PhD |
Innovation Grants |
2021 |
Michigan |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |